Macrogenics Inc (MGNX)
3.715
-0.16
(-4.01%)
USD |
NASDAQ |
Nov 04, 13:14
Macrogenics Total Assets (Quarterly): 201.14M for June 30, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 201.14M |
| March 31, 2024 | 248.28M |
| December 31, 2023 | 298.42M |
| September 30, 2023 | 339.97M |
| June 30, 2023 | 305.65M |
| March 31, 2023 | 343.50M |
| December 31, 2022 | 280.47M |
| September 30, 2022 | 195.35M |
| June 30, 2022 | 218.04M |
| March 31, 2022 | 271.44M |
| December 31, 2021 | 335.24M |
| September 30, 2021 | 392.16M |
| June 30, 2021 | 425.91M |
| March 31, 2021 | 435.44M |
| December 31, 2020 | 378.74M |
| September 30, 2020 | 374.38M |
| June 30, 2020 | 327.59M |
| March 31, 2020 | 265.41M |
| December 31, 2019 | 312.50M |
| September 30, 2019 | 351.45M |
| June 30, 2019 | 383.68M |
| March 31, 2019 | 414.64M |
| December 31, 2018 | 332.13M |
| Date | Value |
|---|---|
| September 30, 2018 | 355.36M |
| June 30, 2018 | 386.89M |
| March 31, 2018 | 326.08M |
| December 31, 2017 | 373.88M |
| September 30, 2017 | 241.84M |
| June 30, 2017 | 274.85M |
| March 31, 2017 | 274.72M |
| December 31, 2016 | 311.26M |
| September 30, 2016 | 339.86M |
| June 30, 2016 | 368.85M |
| March 31, 2016 | 325.66M |
| December 31, 2015 | 359.27M |
| September 30, 2015 | 384.09M |
| June 30, 2015 | 254.20M |
| March 31, 2015 | 278.07M |
| December 31, 2014 | 173.89M |
| September 30, 2014 | 193.62M |
| June 30, 2014 | 205.72M |
| March 31, 2014 | 210.17M |
| December 31, 2013 | 125.78M |
| September 30, 2013 | 41.98M |
| June 30, 2013 | 42.18M |
| December 31, 2012 | 53.75M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
195.35M
Minimum
Sep 2022
435.44M
Maximum
Mar 2021
313.14M
Average
312.50M
Median
Dec 2019
Total Assets (Quarterly) Benchmarks
| Zimmer Biomet Holdings Inc | 21.72B |
| Penumbra Inc | 1.479B |
| Apellis Pharmaceuticals Inc | 904.48M |
| NovaBay Pharmaceuticals Inc | 3.925M |
| Palatin Technologies Inc | 10.74M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 143.32M |
| Shareholders Equity (Quarterly) | 57.82M |
| Current Ratio | 2.710 |